55
Participants
Start Date
October 31, 2004
Primary Completion Date
April 30, 2008
Study Completion Date
April 30, 2008
imatinib
Novartis Investigative Site, Aviano
Novartis Investigative Site, Bologna
Novartis Investigative Site, Candiolo
Novartis Investigative Site, Florence
Novartis Investigative Site, Milan
Novartis Investigative Site, Napoli
Novartis Investigative Site, Padua
Novartis Investigative Site, Pisa
Novartis Investigative Site, Roma
Novartis Investigative Site, Rozzano
Novartis Investigative Site, Torino
Novartis Investigative Site, Lausanne
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY